The Patent Finder

Nostrum Pharmaceuticals, LLC

Also on record
Records under this name other than patents Nostrum Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Nostrum Pharmaceuticals, LLC

PatentTitleStatus Expires Confidence
US 8,545,882Control release formulation containing a hydrophobic material as the sustained release agent
Term ended
Term ended Jul 29, 2025 · From the USPTO record
Term endedTerm ended Jul 29, 2025From the USPTO record
US 8,507,000Controlled release formulation of erythromycin derivatives
Term ended
Term ended May 6, 2024 · From the USPTO record
Term endedTerm ended May 6, 2024From the USPTO record
US 10,391,419Isolation and purification of conjugated estrogens
Lapsed on the fee record
Ended Aug 27, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 27, 2023From the USPTO record
US 7,897,179Pharmaceutical composition containing water soluble drug
Lapsed on the fee record
Ended Mar 1, 2023 · From the USPTO record
Lapsed on the fee recordEnded Mar 1, 2023From the USPTO record
US 6,946,146Coating for a sustained release pharmaceutical composition
Term ended
Term ended Apr 18, 2022 · From the USPTO record
Term endedTerm ended Apr 18, 2022From the USPTO record
US 6,437,000Controlled release oral dosage for suitable for oral administration
Term ended
Term ended Aug 30, 2020 · From the USPTO record
Term endedTerm ended Aug 30, 2020From the USPTO record
US 6,635,680Controlled release pellet formulation
Term ended
Ended no later than Aug 30, 2020 · From the USPTO record
Term endedEnded no later than Aug 30, 2020From the USPTO record
US 6,416,786Sustained release tablet containing hydrocolloid and cellulose ether
Term ended
Term ended Dec 10, 2019 · From the USPTO record
Term endedTerm ended Dec 10, 2019From the USPTO record
US 8,906,419Pharmaceutical composition containing water soluble drug
Lapsed on the fee record
Ended Dec 9, 2018 · From the USPTO record
Lapsed on the fee recordEnded Dec 9, 2018From the USPTO record
US 7,052,706Control release formulation containing a hydrophobic material as the sustained release agent
Lapsed on the fee record
Ended May 30, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 30, 2018From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited